GPCRs - Targeted Drug Discovery Summit 2022
Evvnt Promotion / evvnt
Archivio
22.03.2022 - 24.03.2022 Online
Time: 08:00 - 17:00
Temi della conferenza
The inaugural GPCRs - Targeted Drug Discovery Summit has been established to tap into new drug discovery opportunities in undrugged and orphaned GPCRs by better understanding the complex signaling GPCR pathway, leveraging new structural and genetic data as well as, emerging screening tools and technologies and up and coming modalities.
The inaugural GPCRs - Targeted Drug Discovery Summit has been established to tap into new drug discovery opportunities in undrugged and orphaned GPCRs by better understanding the complex signaling GPCR pathway, leveraging new structural and genetic data as well as, emerging screening tools and technologies and up and coming modalities.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Speakers: Christel Menet, CSO, Confo Therapeutics, Christian Cortis, COO, Tectonic Therapeutic, Graeme Milligan, Professor of Biochemistry, University of Glasgow, Michael Hanson, CTO, ShouTi and more
Speakers: Christel Menet, CSO, Confo Therapeutics, Christian Cortis, COO, Tectonic Therapeutic, Graeme Milligan, Professor of Biochemistry, University of Glasgow, Michael Hanson, CTO, ShouTi and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/947654-2?pid=4832
Mr. Hanson Wade
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
USD 1899.0 - USD 3697.0
USD 1899.0 - USD 3697.0
I partecipanti attesi
1000
1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
